Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
LYSOGENE logo

LYSOGENE

Recent Finacing

Debt

Recent Raise

$17M

Lysogene is a biotech company developing intracerebral gene therapies for CNS lysosomal storage and neurodegenerative disorders, with clinical-stage programs for Sanfilippo syndrome type A and GM1 gangliosidosis.

Founded 2009
Ile-de-France, France
11-50
Publicly Traded
lysogene.com

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Pharmaceutical

Recent Investors

Sofinnova Partners logo
N
Bpifrance logo
European Investment Bank logo

Financials

$27.3M

Total Raised

2

Funding rounds

3

Investors


Team

Upgrade to view the team

See the team members at LYSOGENE.